Jamieson Wellness, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CA4707481046
CAD
36.48
-0.3 (-0.82%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

264.0 k

Shareholding (Sep 2025)

FII

0.00%

Held by 0 FIIs

DII

100.00%

Held by 0 DIIs

Promoter

0.00%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

High Management Efficiency with a high ROCE of 12.41%

 
2

Healthy long term growth as Net Sales has grown by an annual rate of 15.17%

 
3

With a growth in Operating Profit of 161.91%, the company declared Very Positive results in Mar 26

4

With ROE of 15.01%, it has a fair valuation with a 3.05 Price to Book Value

5

Below par performance in long term as well as near term

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

CAD 1,500 Million (Small Cap)

stock-summary
P/E

20.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.83

stock-summary
Return on Equity

15.01%

stock-summary
Price to Book

3.05

Revenue and Profits:
Net Sales:
170 Million
(Quarterly Results - Mar 2026)
Net Profit:
10 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
8.77%
0%
8.77%
6 Months
10.61%
0%
10.61%
1 Year
-0.22%
0%
-0.22%
2 Years
30.61%
0%
30.61%
3 Years
23.83%
0%
23.83%
4 Years
5.65%
0%
5.65%
5 Years
9.58%
0%
9.58%

Jamieson Wellness, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
15.17%
EBIT Growth (5y)
12.45%
EBIT to Interest (avg)
7.64
Debt to EBITDA (avg)
2.95
Net Debt to Equity (avg)
0.79
Sales to Capital Employed (avg)
0.83
Tax Ratio
31.59%
Dividend Payout Ratio
58.96%
Pledged Shares
0
Institutional Holding
0.06%
ROCE (avg)
12.41%
ROE (avg)
11.77%

Valuation key factors

Factor
Value
P/E Ratio
20
Industry P/E
Price to Book Value
3.05
EV to EBIT
15.36
EV to EBITDA
13.24
EV to Capital Employed
2.12
EV to Sales
2.26
PEG Ratio
0.28
Dividend Yield
NA
ROCE (Latest)
13.77%
ROE (Latest)
15.01%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bullish
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Sep 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 1 Schemes (0.11%)

Foreign Institutions

Held by 0 Foreign Institutions (0%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 16.30% vs 14.06% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 484.00% vs 32.43% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "169.80",
          "val2": "146.00",
          "chgp": "16.30%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "19.20",
          "val2": "8.30",
          "chgp": "131.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "5.10",
          "val2": "7.20",
          "chgp": "-29.17%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "9.60",
          "val2": "-2.50",
          "chgp": "484.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "83.40%",
          "val2": "24.30%",
          "chgp": "5.91%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 12.03% vs 8.52% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 26.22% vs 11.09% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "822.10",
          "val2": "733.80",
          "chgp": "12.03%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "133.40",
          "val2": "112.40",
          "chgp": "18.68%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "25.80",
          "val2": "29.00",
          "chgp": "-11.03%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "3.80",
          "val2": "12.40",
          "chgp": "-69.35%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "64.50",
          "val2": "51.10",
          "chgp": "26.22%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "138.40%",
          "val2": "127.90%",
          "chgp": "1.05%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - YoYstock-summary

Mar'26
Mar'25
Change(%)
Net Sales
169.80
146.00
16.30%
Operating Profit (PBDIT) excl Other Income
19.20
8.30
131.33%
Interest
5.10
7.20
-29.17%
Exceptional Items
0.00
0.00
Consolidate Net Profit
9.60
-2.50
484.00%
Operating Profit Margin (Excl OI)
83.40%
24.30%
5.91%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in quarter ended Mar 2026 is 16.30% vs 14.06% in Mar 2025

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Mar 2026 is 484.00% vs 32.43% in Mar 2025

Annual Results Snapshot (Consolidated) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
822.10
733.80
12.03%
Operating Profit (PBDIT) excl Other Income
133.40
112.40
18.68%
Interest
25.80
29.00
-11.03%
Exceptional Items
3.80
12.40
-69.35%
Consolidate Net Profit
64.50
51.10
26.22%
Operating Profit Margin (Excl OI)
138.40%
127.90%
1.05%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2025 is 12.03% vs 8.52% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 26.22% vs 11.09% in Dec 2024

stock-summaryCompany CV
About Jamieson Wellness, Inc. stock-summary
stock-summary
Jamieson Wellness, Inc.
Pharmaceuticals & Biotechnology
Jamieson Wellness Inc is a Canada-based company, which operates as the health and wellness company. The Company develops, manufactures and markets brand of vitamins and natural health products. The Company offers vitamins, minerals and supplements (VMS) products and certain over-the-counter remedies through Jamieson and LVHS brands, as well as sports nutrition products through Progressive, Precision and Iron Vegan brands. The Company offers manufacturing and product development services on a contract manufacturing basis to select blue-chip consumer health companies and retailers worldwide. Additionally, the Company also offers services to Strategic Partners Business customers, including regulatory advice, new product development and distribution services and industry insights.
Company Coordinates stock-summary
Company Details
1 Adelaide Street East, Suite 2200 , TORONTO CA : M5C 2V9
stock-summary
Tel: 1 416 96000521 416 7055437
stock-summary
Registrar Details